Eintrag weiter verarbeiten
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
Gespeichert in:
Zeitschriftentitel: | OncoTargets and Therapy |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | OncoTargets and Therapy, Volume 12, 2019, S. 5305-5309 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Informa UK Limited
|
Schlagwörter: |
author_facet |
Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui |
---|---|
author |
Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui |
spellingShingle |
Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui OncoTargets and Therapy Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report Pharmacology (medical) Oncology |
author_sort |
zhou, li |
spelling |
Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s206732 <p>Efficacy of afatinib in a <em>HER2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p> OncoTargets and Therapy |
doi_str_mv |
10.2147/ott.s206732 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNjczMg |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNjczMg |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
imprint |
Informa UK Limited, 2019 |
imprint_str_mv |
Informa UK Limited, 2019 |
issn |
1178-6930 |
issn_str_mv |
1178-6930 |
language |
English |
mega_collection |
Informa UK Limited (CrossRef) |
match_str |
zhou2019efficacyofafatinibinaher2amplificationpositiveendometrioidadenocarcinomapatientacasereport |
publishDateSort |
2019 |
publisher |
Informa UK Limited |
recordtype |
ai |
record_format |
ai |
series |
OncoTargets and Therapy |
source_id |
49 |
title |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_unstemmed |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_full |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_fullStr |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_full_unstemmed |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_short |
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
|
title_sort |
<p>efficacy of afatinib in a <em>her2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p> |
topic |
Pharmacology (medical) Oncology |
url |
http://dx.doi.org/10.2147/ott.s206732 |
publishDate |
2019 |
physical |
5305-5309 |
description |
|
container_start_page |
5305 |
container_title |
OncoTargets and Therapy |
container_volume |
Volume 12 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792328017817632774 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:46:35.483Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Efficacy+of+afatinib+in+a+HER2+amplification-positive+endometrioid+adenocarcinoma+patient%E2%80%93+a+case+report%0A&rft.date=2019-07-01&genre=article&issn=1178-6930&volume=Volume+12&spage=5305&epage=5309&pages=5305-5309&jtitle=OncoTargets+and+Therapy&atitle=%3Cp%3EEfficacy+of+afatinib+in+a+%3Cem%3EHER2%3C%2Fem%3E+amplification-positive+endometrioid+adenocarcinoma+patient%E2%80%93+a+case+report%3C%2Fp%3E&aulast=Yang&aufirst=Hui&rft_id=info%3Adoi%2F10.2147%2Fott.s206732&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792328017817632774 |
author | Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui |
author_facet | Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui, Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui |
author_sort | zhou, li |
container_start_page | 5305 |
container_title | OncoTargets and Therapy |
container_volume | Volume 12 |
description | |
doi_str_mv | 10.2147/ott.s206732 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczIwNjczMg |
imprint | Informa UK Limited, 2019 |
imprint_str_mv | Informa UK Limited, 2019 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
issn | 1178-6930 |
issn_str_mv | 1178-6930 |
language | English |
last_indexed | 2024-03-01T12:46:35.483Z |
match_str | zhou2019efficacyofafatinibinaher2amplificationpositiveendometrioidadenocarcinomapatientacasereport |
mega_collection | Informa UK Limited (CrossRef) |
physical | 5305-5309 |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Informa UK Limited |
record_format | ai |
recordtype | ai |
series | OncoTargets and Therapy |
source_id | 49 |
spelling | Zhou, Li Ren, Yifeng Wang, Xia Miao, Dongliu Lizaso, Analyn Li, Haiyan Han-Zhang, Han Qian, Jun Yang, Hui 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s206732 <p>Efficacy of afatinib in a <em>HER2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p> OncoTargets and Therapy |
spellingShingle | Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui, OncoTargets and Therapy, Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report , Pharmacology (medical), Oncology |
title | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
title_full | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
title_fullStr | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
title_full_unstemmed | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
title_short | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
title_sort | <p>efficacy of afatinib in a <em>her2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p> |
title_unstemmed | Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report |
topic | Pharmacology (medical), Oncology |
url | http://dx.doi.org/10.2147/ott.s206732 |